AbbVie PE ratio ABBV

Share price divided by earnings per share over the last twelve months, since 2014.

Today, Oct 23, 2026: 80.7×
10-year median: 27.9×
Against its 10-year history: 88th; percentile: 0 is its lowest day, 100 its highest
10-year range: 13.0× to 179×
Peer median: 39.7×

AbbVie's PE ratio is 80.7× as of Oct 23, 2026: a share price of $285.64 against $3.54 of earnings per share over the last twelve months.

That is above its ten-year median of 27.9×, higher than on 88% of days in the last ten years.

Over that time it ranged from 13.0× in Mar 2020 to 179× in Nov 2025.

The median for 7 large drugmakers of a similar size is 39.7×.

PE ratio over time

median 27.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	80.7×	69.5×	175×
2025	174×	59.1×	179×
2024	61.8×	44.4×	69.3×
2023	42.5×	19.4×	42.5×
2022	21.6×	19.0×	33.8×
2021	32.2×	21.7×	41.8×
2020	22.7×	13.0×	43.3×
2019	41.1×	16.5×	41.1×
2018	18.8×	17.5×	36.3×
2017	23.5×	16.2×	23.9×
2016	16.9×	16.1×	34.8×
2015	35.1×	24.7×	63.5×
2014	29.1×	18.1×	30.3×

Against its peers

Companies in Drug Manufacturers - General nearest AbbVie's size, closest first, today.

Company	PE ratio
ABBVAbbVie	80.7×
JNJJohnson & Johnson	40.0×
MRKMerck	116×
AMGNAmgen	27.3×
LLYEli Lilly and	42.7×
GILDGilead Sciences	n/m
PFEPfizer	39.5×
BMYBristol-Myers Squibb	13.5×
Peer median	39.7×

Where AbbVie ranks

#34of 41Large drugmakers with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on AbbVie

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.